Core Viewpoint - MicroPort Scientific Corporation (微创机器人-B) has successfully completed the world's first "large model autonomous surgery" in vivo animal experiments, utilizing its self-developed "Neuron MicroGenius" multimodal autonomous surgical model, marking a significant milestone in surgical robotics [1] Group 1: Company Achievements - The company’s stock rose over 7% in early trading, currently at 26.7 HKD with a trading volume of 115 million HKD [1] - The autonomous surgery experiment is unprecedented in existing literature and medical practice, showcasing the capability of the surgical robot to perform key surgical steps autonomously in a living animal [1] Group 2: Order Statistics - The company reported that its cumulative order volume for core products, including laparoscopic, orthopedic, and vascular intervention devices, has surpassed 230 units [1] - The Tumi laparoscopic surgical robot has achieved over 160 commercial orders globally, with nearly 120 new orders received this year [1] - According to public statistics, Tumi's global order volume is projected to rank among the top two worldwide by 2025 [1]